Outdated Drivers Are Slowing You Down
One free scan finds every outdated or missing driver and matches the right update for your exact hardware.Free scan · exact hardware matchWindows Errors? Fix Them Before They Spread
Repair common Windows errors and clear accumulated junk for a smoother, more stable PC - no reinstall needed.Free scan · no reinstallArmadin, the AI-native security startup founded by Kevin Mandia, announced a $255.5 million Series B on October 1, 2026, at a company-stated valuation above $2.5 billion. Andreessen Horowitz and Accel co-led the round. Armadin said the financing brings its total funding to $445 million.
What Armadin does
Armadin describes its product as an offensive-security platform that uses specialized AI agents, guided by human experts, to test an organization’s attack surface continuously. The company says the agents look for weaknesses, attempt to exploit and chain them, and present security teams with validated attack paths—routes that could connect an exposed system to further access, lateral movement, or cloud compromise.
Founder and CEO Kevin Mandia introduced the approach in March 2026 as an “intelligent fleet (Armada) of agents and humans” intended to find attack paths continuously. The idea is to give defenders evidence of how weaknesses might combine, rather than only a list of isolated findings, so they can prioritize fixes.
These descriptions reflect Armadin’s product claims, not independently verified performance. The available sources do not provide a third-party technical evaluation, published methodology, or independent results establishing the platform’s effectiveness or safety. Armadin also said its campaigns were running in production for Fortune 500 enterprises and government customers, but did not name those customers; that adoption claim is company-reported.
#1 Best Overall
Funding, valuation, and investors
| Item | What Armadin announced |
|---|---|
| Series B | $255.5 million, announced October 1, 2026; co-led by Andreessen Horowitz and Accel. |
| Valuation | More than $2.5 billion, according to Armadin. |
| Total funding | $445 million, according to Armadin. |
| Earlier financing | $189.9 million in combined seed and Series A funding, announced in March 2026. |
Other Series B participants named by the company were new investors Bain Capital Ventures and Redpoint, and returning investors 8VC, Ballistic Ventures, Google Ventures, In-Q-Tel, Kleiner Perkins, and Menlo Ventures. The financing figures are company-announced amounts, not independently audited financial statements.
How Armadin says it will use the money
Armadin said it plans to use the capital to scale its platform and expand research, training, and go-to-market work. Those plans indicate the company’s intended priorities; they do not, by themselves, establish how quickly the product will scale or what results customers will achieve.
What the CrowdStrike partnership adds
In April 2026, Armadin announced a strategic partnership with CrowdStrike. Armadin said its role would be continuous offensive testing, while CrowdStrike’s experts and ecosystem would help prioritize findings, remediate weaknesses, and harden defenses. The announcement describes a partnership around testing and response; it does not establish a referral, reseller, or affiliate arrangement.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.What the valuation does—and does not—tell you
A valuation above $2.5 billion is the figure Armadin reported alongside its financing announcement. It is not the same thing as revenue, profit, cash raised, or a public-market price: the $255.5 million is the amount raised in this round, while the valuation is the company’s stated worth in the financing context. The announcement does not provide enough information to assess the valuation against Armadin’s revenue, customer retention, or operating costs.
What’s actually slowing this PC down?
Pick the symptom - the matching free tool is one click away.
Rank #3
For enterprise buyers, the funding announcement alone cannot establish whether Armadin is a better fit than periodic penetration testing or other security tools. Relevant diligence questions include how often testing runs, what systems and actions are in scope, what safety controls govern agent activity, how findings connect to remediation workflows, whether independent validation is available, and the total cost. The available sources do not provide comparable competitor data on those points.
Quick Recap
Best Value
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
